Novel Urinary Biomarkers and Chronic Kidney Disease After Coronary Angiography: A Prospective Case-Controlled Study


  • Amin Roshdy Soliman Department of Internal Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt
  • Ahmed Yosry Department of Cardiology, Faculty of Medicine, Zagazig University, Zagazig, Egypt
  • Hussein H. Samir Department of Internal Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt
  • Tarek Abdelaziz Department of Internal Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt
  • Haytham Soliman Department of Cardiology, Faculty of Medicine, Zagazig University, Zagazig, Egypt
  • Rabab Mahmoud Ahmed Department of Internal Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt



Biomarkers, Kidney disease, Coronary angiography, KIM-1 protein, L-FABP, Liver fatty acid-binding protein, Kidney injury molecule 1 protein


BACKGROUND: Novel urinary biomarkers may have potential for early detection of acute kidney injury.

AIM: The aim of the study was to test two urinary biomarkers: Kidney injury molecule-1(KIM-1) and liver-type fatty acid binding protein (L-FABP) as markers of kidney injury following coronary angiography.

METHODS: This is a prospective non-randomized controlled trial, performed in two large teaching hospitals. Patients were recruited from the catheter lab or form nephrology outpatient clinics. In group (A), 100 patients with AKI on top of CKD after coronary angiography and Group B: Thirty-one patients with stable CKD as a control. KIM-1 and L-FABP were measured at base line and after 3 months.

RESULTS: In group (A), 100 patients who had acute on top of CKD after coronary angiography, stage progression occurred in 15 patients in group (A) compared to two patients in group (B) (p = 0.28). The median change in eGFR after 3 months was not statistically significant between both groups (p = 0.8). Median baseline urinary liver-type fatty acid binding protein was higher in Group A compared to Group B (3.7 μg/g vs. 1.82μg/g). The change in L-FABP from baseline to 3 months was significant between both groups (p < 0.001). The median urinary concentrations of KIM-1 and L-FABP were higher at the end of the follow-up compared to base line values in both groups, (p < 0.000).

CONCLUSION: Urinary L-FABP correlates with kidney function decline in patients with acute on top of CKD after coronary angiography. Urinary levels of KIM-1 and L-FABP at 3 months increase significantly compared to baseline in patients with progressive CKD.


Download data is not yet available.


Metrics Loading ...

Plum Analytics Artifact Widget Block


Hsu RK, Hsu CY. The role of acute kidney injury in chronic kidney disease. Semin Nephrol. 2016;36(4):283-92. PMid:27475659

Newsome BB, Warnock DG, McClellan WM, Herzog CA, Kiefe CI, Eggers PW, et al. Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med. 2008;168(6):609-16. PMid:18362253

Parikh CR, Coca SG, Wang Y, Masoudi FA, Krumholz HM. Long-term prognosis of acute kidney injury after acute myocardial infarction. Arch Intern Med. 2008;168(9):987-95. PMid:18474763

Okusa MD, Chertow GM, Portilla D. The nexus of acute kidney injury, chronic kidney disease, and world kidney day 2009. Clin J Am Soc Nephrol. 2009;4(3):520-2. PMid:19225036

Hsu C. Where is the epidemic in kidney disease? J Am Soc Nephrol. 2010;21(10):1607-11. PMid:20813868

Chawla LS, Kimmel PL. Acute kidney injury and chronic kidney disease: An integrated clinical syndrome. Kidney Int. 2012;82(5):516-24. PMid:22673882

Sarnak MJ, Levey AS, Schoolwerth AC, Josef C, Bruce C, Lee HL, et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation. 2003;108(17):2154-69. PMid:14581387

Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296-305. PMid:15385656

Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA. 2010;303(5):423-9. PMid:20124537

Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39(5):930-36. PMid:11979336

Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization. The multicenter study of perioperative ischemia research group. Ann Intern Med. 1998;128(3):194-203. PMid:9454527

Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998;104(4):343- 8. PMid:9576407

Sawhney S, Marks A, Fluck N, Levin A, McLernon D, Prescott G, et al. Post-discharge kidney function is associated with subsequent ten-year renal progression risk among survivors of acute kidney injury. Kidney Int. 2017;92(2):440-52. PMid:28416224

Coca SG. Kidney injury biomarkers with clinical utility: Has godot finally arrived? Am J Nephrol. 2019;50:357-60.

Devarajan P. The use of targeted biomarkers for chronic kidney disease. Adv Chronic Kidney Dis. 2010;17(6):469-79. PMid:21044769

Kamijo A, Sugaya T, Hikawa A, Yamanouchi M, Hirata Y, Ishimitsu T, et al. Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease. Mol Cell Biochem. 2006;284(1-2):175-82. s11010-005-9047-9

Nakamura T, Sugaya T, Kawagoe Y, Ueda Y, Osada S, Koide H. Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy. Diabetes Care. 2005;28(11):2728-32. PMid:16249547

Ishimitsu T, Ohta S, Saito M, Teranishi M, Inada H, Yoshii M, et al. Urinary excretion of liver fatty acid-binding protein in health-check participants. Clin Exp Nephrol. 2005;9:34-9.

Humphreys BD, Xu F, Sabbisetti V, Grgic I, Naini SM, Wang N, et al. Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis. J Clin Invest. 2013;123(9):4023-35. PMid:23979159

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013;3:1-150.

Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure definition, outcome measures, animal models, fluid therapy and information technology needs: The second international consensus conference of the acute dialysis quality initiative (ADQI) group. Crit Care. 2004;8(4):R204-12. PMid:15312219

Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: A systematic review and meta-analysis. Kidney Int. 2012;81(5):442-8. ki.2011.379 PMid:22113526

Hsu CY, Chertow GM, McCulloch CE, Fan D, Ordonez JD, Go AS. Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol. 2009;4(5):891-8. PMid:19406959

Lo LJ, Go AS, Chertow GM, McCulloch CE, Fan D, Ordonez JD, et al. Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int. 2009;76(8):893- 9. PMid:19641480

Tan HL, Yap JQ, Qian Q. Acute kidney injury: Tubular markers and risk for chronic kidney disease and end-stage kidney failure. Blood Purif. 2016;41(1-3):144-50. PMid:26764483

Wald R, Quinn RR, Luo J, Li P, Scales DC, Mamdani MM, et al. Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA. 2009;302(11):1179-85. PMid:19755696

van Timmeren MM, van den Heuvel MC, Bailly V, Bakker SJ, van Goor H, Stegeman CA. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol. 2007;212(2):209-17. PMid:17471468

James MT, Ghali WA, Tonelli M, Faris P, Knudtson ML, Pannu N, et al. Acute kidney injury following coronary angiography is associated with a long-term decline in kidney function. Kidney Int. 2010;78(8):803-9. PMid:20686453

Dokken BB. The pathophysiology of cardiovascular disease and diabetes: beyond blood pressure and lipids. Diabetes Spectr. 2008;3:160.

Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, et al. Blood pressure and incidence of twelve cardiovascular diseases: Lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet. 2014;383(9932):1899-911. PMid:24881994

Hsu CY, Ordonez JD, Chertow GM, Fan D, McCulloch CE, Go AS. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int. 2008;74(1):101-7. PMid:18385668714

Venkatachalam MA, Weinberg JM, Kriz W, Bidani AK. Failed tubule recovery, AKI-CKD transition, and kidney disease progression. J Am Soc Nephrol. 2015;26(8):1765-76. PMid:25810494

Garg AX, Devereaux PJ, Yusuf S, Cuerden MS, Parikh CR, Coca SG, et al. Kidney function after off-pump or on-pump coronary artery bypass graft surgery: A randomized clinical trial. JAMA. 2014;311(21):2191-8. PMid:24886787

Watanabe S, Ichikawa D, Sugaya T, Ohata K, Inoue K, Hoshino S, et al. Urinary level of liver-type fatty acid binding protein reflects the degree of tubulointerstitial damage in polycystic kidney disease. Kidney Blood Press Res. 2018;43:1716-29.

Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hikawa A, Hirano N, et al. Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. J Lab Clin Med. 2004;143(1):23-30. PMid:14749682

Lipiec K, Adamczyk P, Świętochowska E, Ziora K, Szczepańska M. L-FABP and IL-6 as markers of chronic kidney damage in children after hemolytic uremic syndrome. Adv Clin Exp Med. 2018;27(7):955-62. PMid:29905409

Connolly M, Kinnin M, McEneaney D, Menown I, Kurth M, Lamont J, et al. Prediction of contrast induced acute kidney injury using novel biomarkers following contrast coronary angiography. QJM Int J Med. 2018;111(2):103-10. https://doi. org/10.1093/qjmed/hcx201




How to Cite

Soliman AR, Yosry A, Samir HH, Abdelaziz T, Soliman H, Ahmed RM. Novel Urinary Biomarkers and Chronic Kidney Disease After Coronary Angiography: A Prospective Case-Controlled Study. Open Access Maced J Med Sci [Internet]. 2020 Sep. 23 [cited 2022 Aug. 14];8(B):1029-35. Available from: